Dose Assessment of Melatonin in Sepsis Trial
NCT02319265
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Study registered elsewhere and is not covered by FDA
Conditions
Sepsis
Interventions
DRUG:
Melatonin
Sponsor
University of Aberdeen